Interleukin-21 plus panobinostat re-program effector cells to a more persistent type of T cell HOUSTON – Treating T cells harvested from a patient with a combination of an epigenetic drug and a cytokine while expanding the cells in the lab […]
Interleukin-21 plus panobinostat re-program effector cells to a more persistent type of T cell HOUSTON – Treating T cells harvested from a patient with a combination of an epigenetic drug and a cytokine while expanding the cells in the lab […]